Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Proteomics studies typically aim to exhaustively detect peptides/proteins in a given biological sample. Over the past decade, the number of publications using proteomics methodologies has exploded. This was made possible due to the availability of high-quality genomic data and many technological advances in the fields of microfluidics and mass spectrometry. Proteomics in biomedical research was initially used in 'functional' studies for the identification of proteins involved in pathophysiological processes, complexes and networks. Improved sensitivity of instrumentation facilitated the analysis of even more complex sample types, including human biological fluids. It is at that point the field of clinical proteomics was born, and its fundamental aim was the discovery and (ideally) validation of biomarkers for the diagnosis, prognosis, or therapeutic monitoring of disease. Eventually, it was recognized that the technologies used in clinical proteomics studies [particularly liquid chromatography-tandem mass spectrometry (LC-MS/MS)] could represent an alternative to classical immunochemical assays. Prior to deploying MS in the measurement of peptides/proteins in the clinical laboratory, it seems likely that traditional proteomics workflows and data management systems will need to adapt to the clinical environment and meet in vitro diagnostic (IVD) regulatory constraints. This defines a new field, as reviewed in this article, that we have termed quantitative Clinical Chemistry Proteomics (qCCP).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS
Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., & Gygi, S. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832254100 · Cited by 1,733
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
Anderson, L., & Hunter, C. L. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500331-mcp200 · Cited by 1,230
Approved IFCC reference method for the measurement of HbA1c in human blood
Jeppsson, J.-O., Kobold, U., Barr, J., Finke, A., Hoelzel, W., Hoshino, T., Miedema, K., Mosca, A., Mauri, P., Paroni, R., et al. (2002) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2002.016 · Cited by 655
Prakash, A., Tomazela, D. M., Frewen, B., MacLean, B., Merrihew, G., Peterman, S., & MacCoss, M. J. (2009) · Journal of Proteome Research · doi:10.1021/pr801028b · Cited by 147
Agger, S. A., Marney, L. C., & Hoofnagle, A. N. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.152264 · Cited by 143
Self-citationZhang, G., Zhang, Y., Fast, D. M., Lin, Z., & Steenwyk, R. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.04.041 · Cited by 79
Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry
Wildsmith, K. R., Han, B., & Bateman, R. J. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.07.049 · Cited by 31
Cited by
Barthélemy, N. R., Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150962 · Cited by 139
Self-citationQuantifying Protein Measurands by Peptide Measurements: Where Do Errors Arise?
van den Broek, I., Romijn, F. P. H. T. M., Smit, N. P. M., van der Laarse, A., Drijfhout, J. W., van der Burgt, Y. E. M., & Cobbaert, C. M. (2015) · Journal of Proteome Research · doi:10.1021/pr5011179 · Cited by 49
van den Broek, I., Smit, N. P. M., Romijn, F. P. H. T. M., van der Laarse, A., Deelder, A. M., van der Burgt, Y. E. M., & Cobbaert, C. M. (2013) · Journal of Proteome Research · doi:10.1021/pr400763d · Cited by 49
Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
Renee Ruhaak, L., van der Laarse, A., & Cobbaert, C. M. (2019) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563219827620 · Cited by 38
“Mass spectrometry (MS) is a strategic (antibody-independent) technology for highly multiplexed protein quantification, that has recently entered the medical laboratory.(26,27) Multiple clinically relevant (apolipo)proteins can simultaneously be enzymatically digested,(28) upon which proteinspecific signature peptides…”
BackgroundQuantification of seven apolipoproteins in human plasma by proteotypic peptides using fast LC‐MS/MS
Ceglarek, U., Dittrich, J., Becker, S., Baumann, F., Kortz, L., & Thiery, J. (2013) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300034 · Cited by 38
Self-citation
Metadata
- Authors
- Lehmann, S., Hoofnagle, A., Hochstrasser, D., Brede, C., Glueckmann, M., Cocho, J. A., Ceglarek, U., Lenz, C., Vialaret, J., Scherl, A., & Hirtz, C.
- Venue
- Clinical Chemistry and Laboratory Medicine
- Publisher
- Walter de Gruyter GmbH
- Published
- 2013-01-01
- Volume
- 51
- Issue
- 5
- Pages
- 919-35
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W2009738094
- Cited by
- 59
- References
- 10
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application. https://app.cochat.ai/papers/10.1515/cclm-2012-0723
- The paper
- Lehmann, S., Hoofnagle, A., Hochstrasser, D., Brede, C., Glueckmann, M., Cocho, J. A., Ceglarek, U., Lenz, C., Vialaret, J., Scherl, A., & Hirtz, C. (2013). Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application. Clinical Chemistry and Laboratory Medicine. https://doi.org/10.1515/cclm-2012-0723
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.